Schedule 13D ownership disclosure
CARTESIAN THERAPEUTICS INC
Security class unavailable · CUSIP: 816212104
Event date: 2020-10-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 23,936,974
- Percent of class
- 22.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-033067
- Form type
- SC 13D
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Oct 23, 2020
- Reporting period
- Oct 20, 2020
- Description
- Schedule 13D beneficial ownership